C12Y 207/08017
Udp-n-acetylglucosamine--lysosomal-enzyme n-acetylglucosaminephosphotransferase
Official title: UDP-N-acetylglucosamine--lysosomal-enzyme N-acetylglucosaminephosphotransferase (2.7.8.17)
C12Y207/08017 (Udp-n-acetylglucosamine--lysosomal-enzyme n-acetylglucosaminephosphotransferase) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 7
- Assignees
- 6
- Inventors
- 21
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 2 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Recent patents
- Vector compositions and methods of using same for treatment of lysosomal storage disorders9 Dec 2025US 12,492,412 B2M6P Terapeutics (Switzerland) LLC
- Compositions comprising a modified GIcNAc-1-phosphotransferase and methods of use thereof22 Aug 2023US 11,732,249 B2Washington University
- Compositions comprising a modified GIcNAc-1-phosphotransferase and methods of use thereof2 Feb 2021US 10,907,139 B2
- Mannose-6-phosphate bearing peptides fused to lysosomal enzymes28 Jul 2020US 10,722,559 B2Shire Human Genetic Therapies, Inc.
- Compositions and methods of using two-promoter vector for treatment of lysosomal storage disorders1 May 2025US 2025/0137012 A1
- Vector compositions and methods of using same for treatment of lysosomal storage disorders1 Dec 2022US 2022/0380800 A1M6P Therapeutics (Switzerland) LLC
- Compositions comprising a modified gicnac-1-phosphotransferase and methods of use thereof17 Jun 2021US 2021/0180035 A1Washington University
- Mannose-6-phosphate bearing peptides fused to lysosomal enzymes3 Dec 2020US 2020/0376095 A1Shire Human Genetic Therapies, Inc.
- Adeno-associated viral vectors for treating mucolipidosis type ii20 Aug 2020US 2020/0261598 A1Genzyme Corporation
Most cited
By later US patents